K-Bio Challenges FDA's New Drug Korean pharmaceutical and biotech companies are embarking on a full-scale challenge to secure new drug approvals from the U.S. Food and Drug Administration (FD

Korean pharmaceutical and biotech companies are embarking on a full-scale challenge to secure new drug approvals from the U.S. Food and Drug Administration (FDA) starting early this year.
#HLB #K_CAB #FDA #approval #bio #it #itchosun #chosun #SouthKorea #Korea #NewsUpdate